Topical calcineurin inhibitors in systemic lupus erythematosus
Christos E Lampropoulos, David P D’CruzLupus Research Unit, Rayne Institute, St. Thomas’ Hospital, London, UKAbstract: Cutaneous lupus erythematosus (CLE) encompasses a variety of lesions that may be refractory to systemic or topical agents. Discoid lupus erythematosus (DLE) and...
Saved in:
Main Authors: | Christos E Lampropoulos (Author), David P D’Cruz (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018) -
Experience using low doses of calcineurin inhibitors in the treatment of refractory lupus nephritis
by: César Augusto Restrepo Valencia, et al.
Published: (2014) -
TOPICAL CORTICOSTEROIDS AND TOIPICAL CALCINEURIN INHIBITORS IN STATE OF THE ART STRATEGY OF ATOPIC DERMATITIS TREATMENT
by: A.V. Emelianov
Published: (2006) -
TOPICAL CORTICOSTEROIDS AND TOIPICAL CALCINEURIN INHIBITORS IN STATE OF THE ART STRATEGY OF ATOPIC DERMATITIS TREATMENT
by: A.V. Emelianov
Published: (2006) -
Chronic cutaneous lupus erythematosus with systemic symptoms or systemic lupus erythematosus?
by: Suresh K. Malhotra, et al.
Published: (2016)